The Fed’s aggressive rate hikes to curb sky-high inflation and geopolitical issues have kept the market extremely volatile this year. However, inflation is finally cooling, as indicated by a decline in inflation in October. Also, the core Personal Consumption Expenditures index rose 0.2% month-over-month in October.
Regardless of market conditions, medical stocks tend to perform relatively well due to the inelastic demand for medical products and services. Moreover, the need for accurate medical diagnoses has increased amid the rising number of chronic disease-affected patients globally.
